Efficacy of Tamsulosin Alone or in Combination with Tadalafil in Relieving Benign Prostatic Hyperplasia Symptoms
Abstract
Abstract Background Tadalafil represent the gold standard for the treatment of erectile dysfunction (ED). Moreover, PDE5 inhibitor is proved to be effective also for the treatment of Lower urinary tract symptoms (LUTS) in several preclinical and clinical trials, since they were found to be able to increase oxygenation and blood supply, reduce intra prostatic inflammation and reduce the smooth muscle tone of the Lower urinary Tract. However, it has been suggested that a single drug is not the ideal therapy for relieving LUTS, especially as measured by the Storage International Prostate Symptom score (SIPPS). Therefore, the opportunity to treat LUTS by using tamsulosin alone or in combination with tadalafil may allow new therapeutic Strategies Aim of Work To evaluate the efficacy and safety of tamsulosin (0.4 mg) alone or in combination.with tadalafil (5 mg) for the management of LUTS Patients and Methods This study was randomized controlled trial clinical study that underwent in urology department, Faculty of Medicine, Ain Shams university in the period of 4 months over 120 divided into two groups: Group A: 60 patients received Tamsulosin 0.4 mg once daily with placebo. Group B: 60 patients received Tamsulosin (0.4 mg) in combination with Tadalafil (5 mg) once daily Results and Conclusion Tamsulosin in combination with Tadalafil allows achieving an additional significant improvement of International Prostate Symptom Score (IPSS) and relieving benign prostatic hyperplasia…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 60 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.